https://www.selleckchem.com/products/nu7026.html
This study aimed to assess the utility of contemporary clinical risk scores and explore the ability of two biomarkers [growth differentiation factor-15 (GDF-15) and soluble ST2 (sST2)] to improve risk prediction in elderly patients with cardiogenic shock. Patients (n=219) from the multicentre CardShock study were grouped according to age (elderly ≥75years and younger). Characteristics, management, and outcome between the groups were compared. The ability of the CardShock risk score and the IABP-SHOCK II score to predict in-hospital morta
Curtir
Comentario
Compartilhar
